Virginia Receives $67 Million from First Payment in Opioid Settlement with Johnson & Johnson

Virginia just received its first payment as part of a settlement with the pharmaceutical company Johnson & Johnson. The initial payment is part of approximately $99 million that Virginia will receive over nine years from the company.

The initial payment of $67.4 million — from opioid manufacturer Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson — includes about $11 million for the state, $16 million for localities, and almost $40 million of the payment will be directed to the Opioid Abatement Authority.

“I’m thrilled that the money from these record-breaking settlements is on its way,” Attorney General Jason Miyares said in a statement.